MIR1246 expression in serum and urine was significantly higher in patients with pancreatic cancer than in the healthy controls (p < 0.0001), but the levels in saliva did not differ significantly between the two groups (p = 0.76; Fig. 1). Here, MIR1246 is linked to familial pancreatic carcinoma.